Leukaemia cells with the BIM variation under a microscope. Such cells often don’t respond well to imatinib, a common type of drug used to treat the disease, but when an MCL-1 inhibitor is added, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results